Trial Profile
Phase IIb trial of eltoprazine in adults with attention-deficit hyperactivity disorder
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2015
Price :
$35
*
At a glance
- Drugs Eltoprazine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Amarantus Bioscience Holdings
- 10 Apr 2014 New trial record